跳至主要内容
临床试验/NCT01566968
NCT01566968已完成不适用

Novel Endpoints in Cough Challenge Testing.

Manchester University NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
98
试验地点
1

研究概览

简要总结

The sensitivity of a person's cough reflex can be measured by getting them to breathe in (inhale) irritant chemicals. There are different methods by which subjects are asked to inhale these chemicals, either by taking one deep breath in, or by asking them to just continue to take a number of breaths. The purpose of this clinical research study is to see if the coughing responses are different in healthy people and people with respiratory problems that make them cough when they are given these chemicals in these two methods.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult subjects aged 18 and over.
  • Meet criteria for subject groups as outlined below:
  • Healthy volunteers:
  • Must be non smokers.
  • No history of respiratory disease.
  • Healthy smokers:
  • Current smokers with at least 10 pack year history of smoking.
  • Spirometry within normal limits i.e. FEV1 > 80% predicted and FEV1/FVC ratio of > 75% predicted.
  • Physician diagnosis of asthma
  • Stable asthma.
  • Airway hyperresponsiveness to methacoline; PC20< 16mg/ml.
  • Non smokers or ex-smokers with smoking history of less than 10 pack years.
  • Physician diagnosis of COPD
  • Ex smokers with smoking history of at least 20 pack years
  • Spirometry demonstating evidence of airflow obstruction i.e. FEV1/FVC ratio of < 70%
  • Chronic cough:
  • History of dry cough for at least 8 weeks.
  • Normal chest x ray.
  • Non smokers or ex smokers of less than 10 pack years history of smoking.

排除标准

  • Symptoms of upper respiratory tract infection within the last 4 weeks.
  • Participation in another clinical trial of an investigational drug within 4 weeks.
  • Use of medication likely to alter cough reflex sensitivity i.e. ACE inhibitors, codeine phosphate, morphine sulphate.
  • Patients with severe respiratory disease i.e. FEV1 < 1.0 litre.
  • Use of steroid tablets in previous 2 months or taken more than 3 courses of steroid tablets in the preceding 12 months in subjects with asthma or COPD.
  • Change in asthma treatment in the preceding 6 weeks in asthma group
  • Significant medical co-morbidities likely to affect ability to participate in the trial or affect cough reflex sensitivity e.g. diabetes, stroke, Parkinson's disease, multiple sclerosis etc.

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Novel Endpoints in Cough Challenge Testing | 临床试验